Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage Cocktail for Multidrug-Resistant Bacterial Skin Infections
NCT07619924Phase 1Enrolling by invitation
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2025
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Bacteriophage cocktail spray in bacterial skin infection (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Clinical Cure Rate at End of Treatment at 1 week and Microbiological Eradication Rate at 2 weeks. Started Jan 2025; status: enrolling by invitation.
02
Drugs
Bacteriophage cocktail spray
03
Conditions
bacterial skin infection
Beyond the preview
Go deeper on NCT07619924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07619924.